Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 181

1.

Recent advances in otitis media. 6. Vaccine.

Giebink GS, Kurono Y, Bakaletz LO, Kyd JM, Barenkamp SJ, Murphy TF, Green B, Ogra PL, Gu XX, Patel JA, Heikkinen T, Pelton SI, Hotomi M, Karma P.

Ann Otol Rhinol Laryngol Suppl. 2005 Jan;194:86-103. Review. No abstract available.

PMID:
15700938
2.
3.

Quality control and the identification of vaccine responders using ELISA-derived antibody data.

Le CT, Grambsch PM, Giebink GS.

Stat Med. 2003 Sep 30;22(18):2935-42.

PMID:
12953289
4.

Pneumococcal conjugate vaccines as maternal and infant immunogens: challenges of maternal recruitment.

Daly KA, Toth JA, Giebink GS.

Vaccine. 2003 Jul 28;21(24):3473-8.

PMID:
12850363
5.

Chronic otitis media with effusion sequelae in children treated with tubes.

Daly KA, Hunter LL, Lindgren BR, Margolis R, Giebink GS.

Arch Otolaryngol Head Neck Surg. 2003 May;129(5):517-22.

PMID:
12759263
6.

Analysis by cDNA microarrays of altered gene expression in middle ears of rats following pneumococcal infection.

Lin J, Tsuboi Y, Pan W, Giebink GS, Adams GL, Kim Y.

Int J Pediatr Otorhinolaryngol. 2002 Sep 24;65(3):203-11.

PMID:
12242135
7.

Maternal pneumococcal conjugate immunization protects infant chinchillas in the pneumococcal otitis media model.

Hajek DM, Quartey M, Giebink GS.

Acta Otolaryngol. 2002 Apr;122(3):262-9.

PMID:
12030572
8.

Recent advances in otitis media. 9. Treatment, complications, and sequelae.

Berman S, Casselbrant ML, Chonmaitree T, Giebink GS, Grote JJ, Ingvarsson LB, Linder T, Lous J, Maw AR, Paradise JL, Sando I, Stool SE, Takasaka T.

Ann Otol Rhinol Laryngol Suppl. 2002 Mar;188:102-24. Review. No abstract available.

PMID:
11968857
9.

Induction of mucous cell metaplasia in the middle ear of rats using a three-step method: an improved model for otitis media with mucoid effusion.

Tsuboi Y, Kim Y, Giebink GS, Le C, Paparella MM, Chen N, Schachern PA, Juhn SK, Lin J.

Acta Otolaryngol. 2002 Mar;122(2):153-60.

PMID:
11936906
10.

Microdialysis studies of the middle ear distribution kinetics of amoxicillin in the awake chinchilla.

Huang Y, Ji P, Inano A, Yang Z, Giebink GS, Sawchuk RJ.

J Pharm Sci. 2001 Dec;90(12):2088-98.

PMID:
11745767
11.

The prevention of pneumococcal disease in children.

Giebink GS.

N Engl J Med. 2001 Oct 18;345(16):1177-83. Review. No abstract available.

PMID:
11642234
12.

A multi-laboratory evaluation of an enzyme-linked immunoassay quantitating human antibodies to Streptococcus pneumoniae polysaccharides.

Quataert S, Martin D, Anderson P, Giebink GS, Henrichsen J, Leinonen M, Granoff DM, Russell H, Siber G, Faden H, Barnes D, Madore DV.

Immunol Invest. 2001 Aug;30(3):191-207.

PMID:
11570640
13.

Low cord blood pneumococcal antibody concentrations predict more episodes of otitis media.

Becken ET, Daly KA, Lindgren BR, Meland MH, Giebink GS.

Arch Otolaryngol Head Neck Surg. 2001 May;127(5):517-22.

PMID:
11346426
14.

Otitis media prevention: non-vaccine prophylaxis.

Giebink GS.

Vaccine. 2000 Dec 8;19 Suppl 1:S129-33. Review.

PMID:
11163476
15.

Low cord blood type 14 pneumococcal IgG1 but not IgG2 antibody predicts early infant otitis media.

Lockhart NJ, Daly KA, Lindgren BR, Meland M, Le CT, Giebink GS.

J Infect Dis. 2000 Jun;181(6):1979-82. Epub 2000 May 31.

PMID:
10837178
16.

An analytical model applied to a multicenter pneumococcal enzyme-linked immunosorbent assay study.

Plikaytis BD, Goldblatt D, Frasch CE, Blondeau C, Bybel MJ, Giebink GS, Jonsdottir I, Käyhty H, Konradsen HB, Madore DV, Nahm MH, Schulman CA, Holder PF, Lezhava T, Elie CM, Carlone GM.

J Clin Microbiol. 2000 Jun;38(6):2043-50.

17.

Clinical epidemiology of otitis media.

Daly KA, Giebink GS.

Pediatr Infect Dis J. 2000 May;19(5 Suppl):S31-6. Review. No abstract available.

PMID:
10821470
18.

Update of microbial problems in pediatric otorhinolaryngology: plenary session.

Prellner K, Kahlmeter G, Marchisio P, Giebink GS.

Int J Pediatr Otorhinolaryngol. 1999 Oct 5;49 Suppl 1:S31-5.

PMID:
10577771
19.

Prospective study of tympanic membrane retraction, hearing loss, and multifrequency tympanometry.

Li Y, Hunter LL, Margolis RH, Levine SC, Lindgren B, Daly K, Giebink GS.

Otolaryngol Head Neck Surg. 1999 Nov;121(5):514-22.

PMID:
10547462
20.
21.

Epidemiology of otitis media onset by six months of age.

Daly KA, Brown JE, Lindgren BR, Meland MH, Le CT, Giebink GS.

Pediatrics. 1999 Jun;103(6 Pt 1):1158-66.

PMID:
10353923
22.

Otitis media: the chinchilla model.

Giebink GS.

Microb Drug Resist. 1999 Spring;5(1):57-72. Review.

PMID:
10332723
23.

Pneumococcus activation of the 5-lipoxygenase pathway and production of glycoproteins in the middle ear of rats.

Lin J, Vambutas A, Haruta A, Paparella MM, Giebink GS, Kim Y.

J Infect Dis. 1999 May;179(5):1145-51.

PMID:
10191216
24.

Middle ear fluid cytokine and inflammatory cell kinetics in the chinchilla otitis media model.

Sato K, Liebeler CL, Quartey MK, Le CT, Giebink GS.

Infect Immun. 1999 Apr;67(4):1943-6.

25.

Chronic otitis media with effusion.

Daly KA, Hunter LL, Giebink GS.

Pediatr Rev. 1999 Mar;20(3):85-93; quiz 94.

PMID:
10073070
26.

Acute otitis media: management and surveillance in an era of pneumococcal resistance--a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group.

Dowell SF, Butler JC, Giebink GS, Jacobs MR, Jernigan D, Musher DM, Rakowsky A, Schwartz B.

Pediatr Infect Dis J. 1999 Jan;18(1):1-9. Review. Erratum in: Pediatr Infect Dis J 1999 Apr;18(4):341.

PMID:
9951971
27.

Relationships between otitis media sequelae and age.

Daly KA, Hunter LL, Levine SC, Lindgren BR, Giebink GS.

Laryngoscope. 1998 Sep;108(9):1306-10.

PMID:
9738746
28.

Vaccination against middle-ear bacterial and viral pathogens.

Giebink GS.

Ann N Y Acad Sci. 1997 Dec 29;830:330-52. Review.

PMID:
9616694
29.
30.

Amoxicillin middle ear fluid penetration and pharmacokinetics in children with acute otitis media.

Canafax DM, Yuan Z, Chonmaitree T, Deka K, Russlie HQ, Giebink GS.

Pediatr Infect Dis J. 1998 Feb;17(2):149-56.

PMID:
9493813
31.

Impact of Surgical Treatment on Paranasal Fungal Infections in Bone Marrow Transplant Patients.

Kennedy CA, Adams GL, Neglia JR, Giebink GS.

Otolaryngol Head Neck Surg. 1997 Jun;116(6):610-616. doi: 10.1016/S0194-5998(97)70236-5.

PMID:
29389291
32.

Impact of surgical treatment on paranasal fungal infections in bone marrow transplant patients.

Kennedy CA, Adams GL, Neglia JP, Giebink GS.

Otolaryngol Head Neck Surg. 1997 Jun;116(6 Pt 1):610-6.

PMID:
9215371
33.

Low cord blood pneumococcal immunoglobulin G (IgG) antibodies predict early onset acute otitis media in infancy.

Salazar JC, Daly KA, Giebink GS, Lindgren BR, Liebeler CL, Meland M, Le CT.

Am J Epidemiol. 1997 Jun 1;145(11):1048-56.

PMID:
9169914
34.
35.

Pneumococcal vaccination of children with recurrent sinusitis.

Giebink GS.

Pediatr Infect Dis J. 1997 May;16(5):535-6. No abstract available.

PMID:
9154558
36.
37.

High frequency hearing loss associated with otitis media.

Hunter LL, Margolis RH, Rykken JR, Le CT, Daly KA, Giebink GS.

Ear Hear. 1996 Feb;17(1):1-11.

PMID:
8741962
38.

The family study of otitis media: design and disease and risk factor profiles.

Daly KA, Rich SS, Levine S, Margolis RH, Le CT, Lindgren B, Giebink GS.

Genet Epidemiol. 1996;13(5):451-68.

PMID:
8905392
40.

Randomized trial of the efficacy of trimethoprim-sulfamethoxazole and prednisone in preventing post-tympanostomy tube morbidity.

Daly KA, Giebink GS, Lindgren B, Margolis RH, Westover D, Hunter LL, Le CT, Buran D.

Pediatr Infect Dis J. 1995 Dec;14(12):1068-74.

PMID:
8745020
41.

Atypical mycobacterial otomastoiditis.

TerKonda RP, Levine SC, Duvall AJ 3rd, Giebink GS.

Laryngoscope. 1995 Dec;105(12 Pt 1):1275-8. No abstract available.

PMID:
8523976
42.

Pneumococcal seroepidemiologic study of Colombian and Minnesota children.

Salazar JC, Londoño LJ, Liebeler C, Trujillo FA, Meier J, Giebink GS.

Pediatr Infect Dis J. 1995 Nov;14(11):1001-3. No abstract available.

PMID:
8584338
43.

Treatment of persistent otitis media.

Giebink GS.

Pediatr Infect Dis J. 1995 Oct;14(10):922-3. No abstract available.

PMID:
8584335
44.

Timing of penicillin treatment influences the course of Streptococcus pneumoniae-induced middle ear inflammation.

Sato K, Quartey MK, Liebeler CL, Giebink GS.

Antimicrob Agents Chemother. 1995 Aug;39(8):1896-8.

45.

Knowledge and attitudes of Minnesota primary care physicians about barriers to measles and pertussis immunization.

Zimmerman RK, Giebink GS, Street HB, Janosky JE.

J Am Board Fam Pract. 1995 Jul-Aug;8(4):270-7.

PMID:
7572290
46.

Immunological aspects of otitis media: present views on possibilities of immunoprophylaxis of acute otitis media in infants and children.

Karma PH, Bakaletz LO, Giebink GS, Mogi G, Rynnel-Dagöö B.

Int J Pediatr Otorhinolaryngol. 1995 Jun;32 Suppl:S127-34. Review.

PMID:
7665281
47.

American Public Health Association/American Academy of Pediatrics National Health and Safety Guidelines for Child-Care Programs: featured standards and implementation.

Hawks D, Ascheim J, Giebink GS, Graville S, Solnit AJ.

Pediatrics. 1994 Dec;94(6 Pt 2):1110-2. No abstract available.

PMID:
7971080
48.

Care of mildly ill children in the day-care setting.

Giebink GS, Chang A, Koch PD, Murray DL, Gonzalez GD.

Pediatrics. 1994 Dec;94(6 Pt 2):1024-6. No abstract available.

PMID:
7971046
49.

Respiratory infections in day care.

Schwartz B, Giebink GS, Henderson FW, Reichler MR, Jereb J, Collet JP.

Pediatrics. 1994 Dec;94(6 Pt 2):1018-20. No abstract available.

PMID:
7971043
50.

Immunology: promise of new vaccines.

Giebink GS.

Pediatr Infect Dis J. 1994 Nov;13(11):1064-8. Review. No abstract available.

PMID:
7845742

Supplemental Content

Loading ...
Support Center